Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression

Glioblastoma (GBM) is the most frequent malignant glioma. Treatment of GBM patients is multimodal with maximum surgical resection, followed by concurrent radiation and chemotherapy with the alkylating drug temozolomide (TMZ). The present study aims to identify genes implicated in the acquired resist...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Le Calvé, Benjamin, Rynkowski, Michal, Le Mercier, Marie, Bruyère, Céline, Lonez, Caroline, Gras, Thierry, Haibe-Kains, Benjamin, Bontempi, Gianluca, Decaestecker, Christine, Ruysschaert, Jean-Marie, Kiss, Robert, Lefranc, Florence
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press Inc. 2010
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933693/
https://ncbi.nlm.nih.gov/pubmed/20824049
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items